Buy Granules India; target of Rs 430: ICICI Direct
ICICI Direct is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 430 in its research report dated July 29, 2021.
August 04, 2021 / 05:30 PM IST
ICICI Direct's research report on Granules India
Granules is a large-scale vertically integrated company that manufactures API, intermediates and finished dosages and has seven manufacturing facilities along with B2B & B2C marketing & distribution. Revenues: Formulations – 52%, API (API+PFI) – 48% Top five products (Paracetamol, Ibuprofen, Metformin, Methocarbamol, Guaifenesin) contributed 84% to FY21 revenues
We change our rating from HOLD to BUY due to better clarity and visibility We value Granules at Rs 430 i.e. 15x P/E on FY23E EPS
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.